ID   RCPCMi007-A-1
AC   CVCL_A8DK
SY   IPSFF1S deltab2m cl 12; IPSFF1Sdeltab2m cl12
DR   BioSamples; SAMEA8944453
DR   hPSCreg; RCPCMi007-A-1
DR   Wikidata; Q107116727
RX   PubMed=34237591;
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8DJ ! RCPCMi007-A
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
RX   PubMed=34237591; DOI=10.1016/j.scr.2021.102451;
RA   Bogomiakova, Margarita E.
RA   Sekretova, Elizaveta K.
RA   Eremeev, Artem Valerievich
RA   Shuvalova, Lilia D.
RA   Bobrovsky, Pavel A.
RA   Zerkalenkova, Elena A.
RA   Lebedeva, Olga S.
RA   Lagarkova, Maria A.
RT   "Derivation of induced pluripotent stem cells line (RCPCMi007-A-1)
RT   with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9
RT   genome editing.";
RL   Stem Cell Res. 55:102451-102451(2021).
//